Howard Trachtman
Pediatric Nephrology · New York, NYNPI 1942360011
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $251,859 of the $265,701 with a category attached, or 94.8%. 10 manufacturers reported payments, led by Travere Therapeutics, Inc. at 39.2% of the total. Among pediatric nephrology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $1759.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$104K
- Boehringer Ingelheim$85K
- Boehringer Ingelheim International GmbH$56K
- AstraZeneca$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$5K
- Roche Products Limited$3K
- plus $7K from 4 others
Across 142 payments — averaging $1578.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$161K
- AstraZeneca$45K
- E.r. Squibb & Sons, L.L.C.$11K
- Novartis Pharma AG$5K
- Boehringer Ingelheim International GmbH$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
What the payments were for
- Consulting fees$251,85995%
- Travel & lodging$13,2225%
- Food & beverage$6200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 81 | $104,139 |
| Boehringer Ingelheim | 27 | $85,424 |
| Boehringer Ingelheim International GmbH | 27 | $55,737 |
| AstraZeneca | 3 | $5,350 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $5,260 |
| Roche Products Limited | 1 | $3,220 |
| Akebia Therapeutics Inc | 3 | $2,900 |
| Apellis Pharmaceuticals, Inc. | 1 | $2,142 |
| Astrazeneca UK Limited | 1 | $1,470 |
| Novartis | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$265,701 in reported general payments places this provider in the 95th percentile of 63 pediatric nephrology providers in New York.
Other pediatric nephrology in New York
- Jeffrey SalandNew York$43K
- David GoldsmithNew York$37K
- Hannah KimNew York$2K
- Namrata JainNew York$1K
- Laura Malaga DieguezNew York$473
- Marissa LiptonNew York$379
- Ileana Serrano-HerreraNew York$356
- Rushelle ByfieldNew York$302
- Natalie UyNew York$288
- Hridya SumanNew York$247
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.